Among the many lessons learned from the COVID-19 pandemic is that the world remains dangerously exposed to the novel and unknown health risks, despite exponential developments in our ability to improve and prolong life. Access to the right data could help scientists develop faster responses not only for global pandemics, but also for long-term improvements in […]
WOLF® Benchtop Microfluidic Cell Sorter is now available in Western Europe and East Asia SAN DIEGO — Furthering its commitment to deliver the benefits of simple, high viability cell sorting solutions globally, NanoCellect Biomedical announced it has completed agreements with several key partners to distribute its WOLF® Cell Sorter throughout East Asia and Western Europe. These agreements are a key step in NanoCellect’s […]
Gemini Bio adds Scinus Bioreactor to its portfolio WEST SACRAMENTO, CA and BILTHOVEN, The Netherlands – Gemini Bioproducts, LLC (“Gemini Bio”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Scinus Cell Expansion Netherlands […]
San Diego, Calif. — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced a distribution and partnership agreement with Japan-based, Filgen, to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Japan. NanoCellect’s simple microfluidic benchtop solutions allow researchers to analyze and […]
Sydney, Australia – AXT are proud to announce that they have partnered with France-based Poietis to bring their next-generation bioprinting platforms to Australia. The NGB (Next Generation Bioprinting) system is a world first using laser-assisted bioprinting technology to print cells (from aggregates and cellular spots to single cell) rapidly and precisely in complex cellular formations in […]
Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib CARLSBAD, Calif. — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui Medicine Co., Ltd. (JHM), to develop a CDx that will […]
Rotterdam, The Netherlands, VIROCLINICS-DDL is pleased to announce the signing of a new collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. VIROCLINICS-DDL is the global leader in clinical trial management services, focused on viral targets such as influenza, COVID-19, RSV, HBV and Polio. REPROCELL will provide sample processing services in Japan to VIROCLINICS-DDL and will support […]
BRANFORD, Conn. — IsoPlexis, the leader in single-cell functional proteomics, today announced a partnership with the Division of Infectious Diseases, Department of Medicine at Columbia University, IsoPlexis’ Single-Cell Secretome immune profiling solutions will be used to study cellular drivers of durable and protective immune response to COVID-19. (PRNewsfoto/IsoPlexis) T cell and other immune cell polyfunctional cytokine responses on IsoPlexis’ platform have previously […]
CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer […]
CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
